What fascinates me is that this rise is not driven by short-lived beauty trends, but by a deeper shift in how both brands and consumers evaluate skincare products
Conclusion Across topical and tissue models, GHK-Cu is studied for potential roles in matrix support, wound-area remodeling signals, oxidative balance, and inflammation moderation
FRIDAY, March 6, 2026 (HealthDay News) -- Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes and obesity is independently associated with a significantly increased five-year risk for osteoporosis, gout, and osteomalacia compared with nonuse, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 2 to 6 in New Orleans.Muaaz Wajahath, from the Michigan State University College of Human Medicine in East Lansing, and colleagues evaluated the five-year risk for osteoporosis, gout, and osteomalacia in adults with both type 2 diabetes and obesity treated with GLP-1 RAs (semaglutide, liraglutide, dulaglutide, or exenatide) compared with matched controls (73,483 per group).The researchers found that at five years, patients exposed to GLP-1 RAs had a significantly increased risk for osteoporosis compared with controls (4.1 versus 3.2 percent
Further it was shown that IL-4 which induces LTC4S expression in human mast cells requires CysLTs to promote mast cell proliferation leading to the assumption that autocrine actions of endogenous CysLTs are involved in this effect [51]
While sermorelin stimulates your pituitary gland to release natural growth hormone, testosterone helps increase muscle mass, libido, and mood stability
